Cleveland Research analyst Steve Willoughby says his recent research suggests a "noticeable slowing" in Life Science equipment demand during Q3 in Europe, China, and parts of the U.S. The analyst who adjusted estimates for Thermo Fisher (TMO), Waters (WAT), Agilent (A), Mettler-Toledo (MTD), Avantor (AVTR), PerkinElmer (PKI) and Bruker (BRKR), believes a broader industry slowdown could impact industry multiples which he notes have expanded so far this year.
News For TMO;WAT;A;MTD;AVTR;PKI;BRKR From the Last 2 Days
Deutsche Bank raised the firm's price target on Thermo Fisher to $610 from $600 and keeps a Buy rating on the shares post the Q1 report. The analyst says a solid operational performance drove a strong start to 2024.
Barclays analyst Luke Sergott raised the firm's price target on Thermo Fisher to $615 from $590 and keeps an Equal Weight rating on the shares. The company reported a beat across the board, says the analyst, who sees the business stabilizing.
Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here